Predictors and Timing of Adverse Experiences During Transdermal Nicotine Therapy
- 1 January 1999
- journal article
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 20 (6), 545-555
- https://doi.org/10.2165/00002018-199920060-00007
Abstract
Objectives Difficulty sleeping is arecognised tobacco withdrawal symptom, but sleep problems, like application site reactions, are commonly reported as adverse reactions to transdermal nicotine...Keywords
This publication has 26 references indexed in Scilit:
- The Safety of Transdermal Nicotine as an Aid to Smoking Cessation in Patients with Cardiac DiseaseNew England Journal of Medicine, 1996
- Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers.American Journal of Respiratory and Critical Care Medicine, 1994
- The transdermal nicotine patch: results of a randomised placebo‐controlled trialThe Medical Journal of Australia, 1994
- Effectiveness of a 16-Hour Transdermal Nicotine Patch in a Medical Practice Setting, Without Intensive Group CounselingArchives of Internal Medicine, 1993
- Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice. Imperial Cancer Research Fund General Practice Research Group.BMJ, 1993
- Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital. A placebo-controlled trialArchives of Family Medicine, 1993
- The Local Side Effects of Transdermally Absorbed NicotineSkin Pharmacology and Physiology, 1992
- Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group.1991
- A Double-Blind Trial of a 16-Hour Transdermal Nicotine Patch in Smoking CessationNew England Journal of Medicine, 1991
- Antismoking products.1990